Literature DB >> 19690333

Mitofusin 2 inhibits mitochondrial antiviral signaling.

Kai Yasukawa1, Hiroyuki Oshiumi, Makoto Takeda, Naotada Ishihara, Yusuke Yanagi, Tsukasa Seya, Shun-ichiro Kawabata, Takumi Koshiba.   

Abstract

The innate immune response to viral infection involves the activation of multiple signaling steps that culminate in the production of type I interferons (IFNs). Mitochondrial antiviral signaling (MAVS), a mitochondrial outer membrane adaptor protein, plays an important role in this process. Here, we report that mitofusin 2 (Mfn2), a mediator of mitochondrial fusion, interacts with MAVS to modulate antiviral immunity. Overexpression of Mfn2 resulted in the inhibition of retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA-5), two cytosolic sensors of viral RNA, as well as of MAVS-mediated activation of the transcription factors interferon regulatory factor 3 (IRF-3) and nuclear factor kappaB (NF-kappaB). In contrast, loss of endogenous Mfn2 enhanced virus-induced production of IFN-beta and thereby decreased viral replication. Structure-function analysis revealed that Mfn2 interacted with the carboxyl-terminal region of MAVS through a heptad repeat region, providing a structural perspective on the regulation of the mitochondrial antiviral response. Our results suggest that Mfn2 acts as an inhibitor of antiviral signaling, a function that may be distinct from its role in mitochondrial dynamics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19690333     DOI: 10.1126/scisignal.2000287

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  118 in total

1.  Peroxisomes are signaling platforms for antiviral innate immunity.

Authors:  Evelyn Dixit; Steeve Boulant; Yijing Zhang; Amy S Y Lee; Charlotte Odendall; Bennett Shum; Nir Hacohen; Zhijian J Chen; Sean P Whelan; Marc Fransen; Max L Nibert; Giulio Superti-Furga; Jonathan C Kagan
Journal:  Cell       Date:  2010-05-06       Impact factor: 41.582

Review 2.  Mitochondria and cell signalling.

Authors:  Stephen W G Tait; Douglas R Green
Journal:  J Cell Sci       Date:  2012-02-15       Impact factor: 5.285

Review 3.  The role of DNA exonucleases in protecting genome stability and their impact on ageing.

Authors:  Penelope A Mason; Lynne S Cox
Journal:  Age (Dordr)       Date:  2011-09-23

4.  Mitochondria and antiviral innate immunity.

Authors:  Takumi Koshiba; Nasir Bashiruddin; Shunichiro Kawabata
Journal:  Int J Biochem Mol Biol       Date:  2011-08-15

5.  Listeria infection modulates mitochondrial dynamics.

Authors:  Fabrizia Stavru; Pascale Cossart
Journal:  Commun Integr Biol       Date:  2011-05

Review 6.  Mitochondrial shape changes: orchestrating cell pathophysiology.

Authors:  Silvia Campello; Luca Scorrano
Journal:  EMBO Rep       Date:  2010-08-20       Impact factor: 8.807

7.  Structure-function analysis of the yeast mitochondrial Rho GTPase, Gem1p: implications for mitochondrial inheritance.

Authors:  Takumi Koshiba; Holly A Holman; Kenji Kubara; Kai Yasukawa; Shun-ichiro Kawabata; Koji Okamoto; Jane MacFarlane; Janet M Shaw
Journal:  J Biol Chem       Date:  2010-10-29       Impact factor: 5.157

8.  The microRNAs miR-302b and miR-372 regulate mitochondrial metabolism via the SLC25A12 transporter, which controls MAVS-mediated antiviral innate immunity.

Authors:  Kai Yasukawa; Daisuke Kinoshita; Keisuke Yaku; Takashi Nakagawa; Takumi Koshiba
Journal:  J Biol Chem       Date:  2019-11-25       Impact factor: 5.157

9.  Identifying genetic loci and spleen gene coexpression networks underlying immunophenotypes in BXD recombinant inbred mice.

Authors:  Rachel M Lynch; Sudhir Naswa; Gary L Rogers; Stephen A Kania; Suchita Das; Elissa J Chesler; Arnold M Saxton; Michael A Langston; Brynn H Voy
Journal:  Physiol Genomics       Date:  2010-02-23       Impact factor: 3.107

Review 10.  Mechanisms of MAVS regulation at the mitochondrial membrane.

Authors:  Jana L Jacobs; Carolyn B Coyne
Journal:  J Mol Biol       Date:  2013-10-09       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.